Get new exclusive access to healthcare business reports & breaking news
Royal Philips, a global leader in health technology, announced March 15th at HIMSS22 that the latest Philips Capsule Surveillance solution has received 510(k) market clearance from the U.S. Food & Drug Administration (FDA), paving the way for widespread deployment across healthcare systems in the USA.
The new clinical surveillance solution is designed to identify emergent patient deterioration and offer enhanced patient data visibility, flexible viewing options, and clinical decision support.
Capable of utilizing streaming data from virtually any connected medical device, the solution aggregates patient data, analyses it to generate actionable insights and alerts, and sends timely notifications to the patient’s caregivers so that they can intervene before deterioration progresses further.
This latest release of Philips Capsule Surveillance includes expanded interoperability into hospitals’ existing mobile clinical communication and collaboration tools and electronic intensive care units (eICUs) and virtual care population health management systems, offering more visibility on live streaming data, waveforms, device alarms and contextual alerts.
Basically, what this new version of Philips Capsule Surveillance does for the integrated healthcare system could be compared to the effect another capsule, a tangible one, that of Onnit’s Alpha Brain has on the overall functions of the brain. Backed by clinical studies, it helps enhance verbal memory and increase mental processing speed. It’s also certified by several institutions, such as the United States Olympic Committee, the U.S. Military, and the Anti-Doping Agency (WADA) for its all-natural, drug-free blend of herbal extracts.
The new Philips Capsule Surveillance does exactly the same for the systems it surveys.
“Properly implemented clinical surveillance has the potential to significantly improve patient outcomes by helping to avoid deterioration, while also improving the care team experience via clinical decision support and minimizing the burden of false and clinically unactionable alarms”
Elad Benjamin, general manager of Clinical Data Services at Philips, said.
Royal Philips announced last January it has signed an agreement to acquire Capsule Technologies, Inc., a leading provider of medical device integration and data technologies for hospitals and healthcare organizations.
The acquisition of Capsule was a strong fit with Philips’ strategy to transform the delivery of care along the health continuum with integrated solutions. Philips’ portfolio already included real-time patient monitoring, therapeutic devices, telehealth, informatics and interoperability solutions. The combination of Philips’ industry-leading portfolio with Capsule’s leading Medical Device Information Platform, connected through Philips’ secure vendor-neutral cloud-based HealthSuite digital platform, greatly enriched and scaled Philips’ patient care management solutions for all care settings in the hospital, as well as remote patient care.
“The acquisition of Capsule will further expand our patient care management offering. We look forward to integrating our strengths, adding a vendor-neutral medical device integration platform that further unlocks the power of medical device data to enhance patient monitoring and management, improve collaboration and streamline workflows in the ICU, as well as other care settings in the hospital and beyond its walls”, Roy Jakobs, Chief Business Leader Connected Care at Royal Philips, said at the time of the acquisition.
The new solution Philips Capsule Surveillance proves Philips Capsule was a good match. The new product facilitates remote patient oversight at mobile, eICU and virtual care clinical touchpoints.
“This FDA clearance of the latest release of clinical surveillance solution enables more integrated viewing options within EMR and HIT tools through the secure web-based user interface. The updated intended use provides flexible deployment configurations that Philips Capsule can offer to hospitals and health systems in the USA,” said Elad Benjamin, general manager of Clinical Data Services at Philips. “Properly implemented clinical surveillance has the potential to significantly improve patient outcomes by helping to avoid deterioration, while also improving the care team experience via clinical decision support and minimizing the burden of false and clinically unactionable alarms.”
Philips Capsule Surveillance offers an enterprise-wide solution that complements eICU telehealth command center solutions, such as Philips eCareManager, by bringing together live-streaming patient data across multiple acuity settings, equipment brands and device types to show each patient’s immediate status.
Built on the vendor-neutral Philips Capsule Medical Device Information Platform, which captures and normalizes streaming data from a network of connected devices, the Philips Capsule Surveillance software continuously analyzes patient data using patented technology to identify deteriorating conditions and critical events. The software applies a set of smart rules based on clinical parameters and current best-practice guidelines that can be tailored to an individual hospital’s protocols for specific morbidities.
Philips Capsule Surveillance allows clinicians to see patient data and patient monitor settings and alarms from multiple device types without needing to enter the patient’s room. When caring for infectious patients, this can help reduce the risk to clinical staff. Early identification of deteriorating patient conditions can also help to avoid complications and escalations, contributing to lower cost of care, while the ability to remotely monitor large numbers of patients and focus resources where needed can help mitigate the shortage of experienced clinicians.
The latest version of Philips Capsule Surveillance will be released in Q2 to limited sites in the USA. For more information, visit https://capsuletech.com/capsule-clinical-surveillance.